Welcome to the Cannabis Countdown. In this week’s rendition, we’ll recap and countdown the top 10 Marijuana and Psychedelic Stock News stories for the week of March 23rd – 29th, 2020.
Without further ado, let’s get started.
Canopy Growth (TSX: WEED) (NYSE: CGC) (FRA: 11L1) founder Bruce Linton and Billionaire “Mr. Wonderful” Kevin O’Leary from Shark Tank, are going all-in on what they think is a much bigger opportunity than the Cannabis Boom. Investors who missed the last bull market in Weed Stocks or got in too late should start researching the “Shroom Boom” immediately.
Since reaching new lows during the stock market’s massive Coronavirus correction, most Pot Stocks have reversed sharply and are now soaring at a time no one could have predicted. These 8 Cannabis Stocks have recently soared more than 150%, with 4 posting gains of over 200%.
For the second day in a row, U.S. multi-state operators (MSOs) like Curaleaf (CSE: CURA) (OTCQX: CURLF), which reported earnings today, led the way as the cannabis sector continued its strong performance compared to the broad market.
In an update to clients on Wednesday, Stanley reiterated his “Buy” rating and CDN $22 target price on Curaleaf (CSE: CURA) (OTCQX: CURLF), saying that so far the company’s operations haven’t been disrupted by COVID-19.
Psychedelics firm MindMed (NEO: MMED) (OTC: MMEDF) (FRA: BGHM) announced that the company has begun enrollment in further human safety studies of 18-MC, the company’s orally-active drug candidate for the treatment of opioid use disorders.
A month ago, shares of Canadian licensed producer (LP) Tilray (NASDAQ: TLRY) (FRA: 2HQ) closed at $16.57. On March 25, shares closed at $5.04. In the early afternoon on March 26, the stock traded at around $8.39, up about 67% for the day.
Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF) (FRA: R9U2) announced its 2019 fourth-quarter and full-year Earnings after the market closed on Thursday. Was there news that could help accelerate the stock’s comeback? Here are the highlights from the company’s Q4 update.
Psychedelics stock Champignon Brands (CSE: SHRM) (OTC: SHRMF) (FRA: 496) soared 15% on Wednesday officially breaking out of its bullish chart formation. Following Friday’s very strong close, the probability of SHRM’s uptrend continuing has been increased substantially. Champignon Brands is a leading psychedelics and health and wellness company focused on creating the most compelling IP portfolio, clinical pipeline and drug development platform in the psychedelics space.